Thermo opens India clinical trial services facility
From the $17m, 150,000 sq ft facility located in Ahmedabad in western India Thermo will offer packaging, global distribution and logistics management.
The services are aimed at companies looking to supply pharmaceutical samples to patients participating in clinical trials and have been designed with consideration to regulatory requirements.
Marijn Dekkers, president and CEO of Thermo, said: “We continue to make the investments required to grow our business – in this case expanding our capabilities to support growing clinical research and development markets in India.
“With the added capacity now available to us with this new facility, we can offer our customers a higher level of technology, quality and expertise to facilitate clinical trials that serve the needs of both local and multi-national pharmaceutical companies.”
The opening of the facility complements Thermo’s existing clinical trial services facilities located in the US, Europe and Asia. It also expands on Thermo’s capacity in India, which has undergone considerable development since it first established its presence in 2000.
In 2005 Thermo opened a facility in Mumbai offering laboratory services. Since then this has been supplemented by facilities offering manufacturing, biospecimen storage, life sciences research and environmental analysis.
Thermo has also made two acquisitions to expand its presence in India. Last year the company bought Qualigens Fine Chemicals and this was added to earlier this year through the acquisition of Chemito.
By making these two acquisitions Thermo established itself as a supplier of laboratory chemicals and analytical instruments in India. The company now employees 600 people at its 20 facilities in the country.
